1-Hydroxy-N,N,N-tris(1-hydroxyethyl)ethan-1-aminium bromide | 97515-52-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-Hydroxy-N,N,N-tris(1-hydroxyethyl)ethan-1-aminium bromide
• 英文别名: tetrakis(1-hydroxyethyl)azanium;bromide
• CAS: 97515-52-1
• 化学式: C8H20BrNO4
• 分子量: 274.15
• InChiKey: VCSQHJCVDCUDPL-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -3.84
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  80.9
• 氢给体数：
  4
• 氢受体数：
  5

文献信息

• ORGANIC ELECTROLYTE COMPOUNDS FOR REDOX-FLOW BATTERIES
  申请人：FUNDACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA DE ENERGÍAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA

  公开号：US20180079721A1

  公开（公告）日：2018-03-22

  The present invention relates to redox electrolyte compounds. The present invention further relates to a redox-flow battery wherein one of the catholyte and the anolyte, or both, has the redox electrolyte compound of the invention. The present invention further relates to the method of controlling the redox-flow battery and its use for energy storage.

  本发明涉及氧化还原电解质化合物。本发明还涉及一种氧化还原流电池，其中阴极液和/或阳极液中至少一种含有本发明的氧化还原电解质化合物。本发明还涉及控制氧化还原流电池的方法及其用于储能的用途。
• Organic electrolyte compounds for redox-flow batteries
  申请人：FUNDACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA DE ENERGÍAS ALTERNATIVAS CIC ENERGIGUNE FUNDAZIOA

  公开号：US10710964B2

  公开（公告）日：2020-07-14

  The present invention relates to redox electrolyte compounds. The present invention further relates to a redox-flow battery wherein one of the catholyte and the anolyte, or both, has the redox electrolyte compound of the invention. The present invention further relates to the method of controlling the redox-flow battery and its use for energy storage.

  本发明涉及氧化还原电解质化合物。本发明进一步涉及一种氧化还原液流电池，其中阴离子溶液和阳离子溶液之一或两者都具有本发明的氧化还原电解质化合物。本发明还涉及氧化还原液流电池的控制方法及其储能用途。
• 4-HYDROXY BENZOATE DERIVATIVES FOR USE IN THE TREATMENT OF INFECTION, INFLAMMATION OR PAIN
  申请人：Jordan Roy Arlington

  公开号：US20100292329A1

  公开（公告）日：2010-11-18

  A compound of the general formula (I) is provided for use in the topical treatment of infection, inflammation and/or pain: wherein R 1 independently represents a methylene group, an ethylene group or a straight or branched chain C 3 to C 6 alkylene group; R 2 independently represents a hydrogen atom, a methyl group, an ethyl group or a straight or branched chain C 3 to C 20 alkyl group; x represents 0 or an integer from 1 to 4 and y represents 0 or an integer from 1 to 4, wherein the sum of x and y is 4; and Z represents a hydrogen atom or (HOR 1 ) y R 2 X N + ; compositions including the compound; use of the compound in the manufacture of a medicament; and methods of medical treatment including the topical application of the compound.
• US8785504B2
  申请人：——

  公开号：US8785504B2

  公开（公告）日：2014-07-22
• US9090555B2
  申请人：——

  公开号：US9090555B2

  公开（公告）日：2015-07-28